{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:00:56Z","timestamp":1791687656107,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T00:00:00Z","timestamp":1426723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T00:00:00Z","timestamp":1426723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is currently no biochemical test for detection of early-stage osteoarthritis (eOA). Tests for early-stage rheumatoid arthritis (eRA) such as rheumatoid factor (RF) and anti\u2013cyclic citrullinated peptide (CCP) antibodies require refinement to improve clinical utility. We developed robust mass spectrometric methods to quantify citrullinated protein (CP) and free hydroxyproline in body fluids. We detected CP in the plasma of healthy subjects and surprisingly found that CP was increased in both patients with eOA and eRA whereas anti\u2013CCP antibodies were predominantly present in eRA. A 4-class diagnostic algorithm combining plasma\/serum CP, anti-CCP antibody and hydroxyproline applied to a cohort gave specific and sensitive detection and discrimination of eOA, eRA, other non-RA inflammatory joint diseases and good skeletal health. This provides a first-in-class plasma\/serum-based biochemical assay for diagnosis and type discrimination of early-stage arthritis to facilitate improved treatment and patient outcomes, exploiting citrullinated protein and related differential autoimmunity.<\/jats:p>","DOI":"10.1038\/srep09259","type":"journal-article","created":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T10:14:31Z","timestamp":1426760071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health"],"prefix":"10.1038","volume":"5","author":[{"given":"Usman","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attia","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Filer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Winyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Tarr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Haigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Thornalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,19]]},"reference":[{"key":"BFsrep09259_CR1","unstructured":"Connelly, L. B., Woolf, A. & Brooks, P. [Cost-effectiveness of interventions for musculoskeletal conditions]. Disease Control Priorities in Developing Countries [Jamieson, D. T. et al. (eds.)] [963\u2013980] (World Bank, Washington DC, 2006)."},{"key":"BFsrep09259_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.joca.2011.10.003","volume":"20","author":"L Menashe","year":"2012","unstructured":"Menashe, L. et al. The diagnostic performance of MRI in osteoarthritis: a systematic review and meta-analysis. Osteoarthritis & Cartilage 20, 13\u201321 (2012).","journal-title":"Osteoarthritis & Cartilage"},{"key":"BFsrep09259_CR3","first-page":"231","volume":"32","author":"K Raza","year":"2005","unstructured":"Raza, K. et al. Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J. Rheumatol. 32, 231\u2013238 (2005).","journal-title":"J. Rheumatol."},{"key":"BFsrep09259_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1196\/annals.1443.013","volume":"1143","author":"WJ Van Venrooij","year":"2008","unstructured":"Van Venrooij, W. J., Van Beers, J. J. B. C. & Pruijn, G. J. M. Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann. N.Y. Acad. Sci. 1143, 268\u2013285 (2008).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"BFsrep09259_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrrheum.2011.76","volume":"7","author":"WJ Van Venrooij","year":"2011","unstructured":"Van Venrooij, W. J., van Beers, J. J. B. C. & Pruijn, G. J. M. Anti-CCP antibodies: the past, the present and the future. Nature Rev. Rheumatol. 7, 391\u2013398 (2011).","journal-title":"Nature Rev. Rheumatol."},{"key":"BFsrep09259_CR6","first-page":"97","volume":"26","author":"MJ Seibel","year":"2005","unstructured":"Seibel, M. J. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin. Biochem. Rev. 26, 97\u2013122 (2005).","journal-title":"Clin. Biochem. Rev."},{"key":"BFsrep09259_CR7","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1359\/jbmr.1997.12.10.1714","volume":"12","author":"CM Weaver","year":"1997","unstructured":"Weaver, C. M. et al. Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females. J. Bone & Mineral Res. 12, 1714\u20131720 (1997).","journal-title":"J. Bone & Mineral Res."},{"key":"BFsrep09259_CR8","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1136\/ard.2005.044743","volume":"65","author":"Y Takizawa","year":"2006","unstructured":"Takizawa, Y. et al. Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids. Ann. Rheumatic Dis. 65, 1013\u20131020 (2006).","journal-title":"Ann. Rheumatic Dis."},{"key":"BFsrep09259_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random Forests. Machine learning 45, 5\u201332 (2001).","journal-title":"Machine learning"},{"key":"BFsrep09259_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J. Statistical Software 33, 1\u201322 (2010).","journal-title":"J. Statistical Software"},{"key":"BFsrep09259_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10462-009-9124-7","volume":"33","author":"L Rokach","year":"2010","unstructured":"Rokach, L. Ensemble-based classifiers. Artif. Intell. Rev. 33, 1\u201339 (2010).","journal-title":"Artif. Intell. Rev."},{"key":"BFsrep09259_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bone.2012.04.001","volume":"51","author":"JC Rousseau","year":"2012","unstructured":"Rousseau, J. C. & Garnero, P. Biological markers in osteoarthritis. Bone 51, 265\u2013277 (2012).","journal-title":"Bone"},{"key":"BFsrep09259_CR13","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1186\/ar3555","volume":"14","author":"D Sohn","year":"2012","unstructured":"Sohn, D. et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Research & Therapy 14, R7 (2012).","journal-title":"Arthritis Research & Therapy"},{"key":"BFsrep09259_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/ar2655","volume":"11","author":"SB Abramson","year":"2009","unstructured":"Abramson, S. B. & Attur, M. Developments in the scientific understanding of osteoarthritis. Arthritis Research & Therapy 11, 227\u2013236 (2009).","journal-title":"Arthritis Research & Therapy"},{"key":"BFsrep09259_CR15","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1002\/art.22983","volume":"56","author":"C Foulquier","year":"2007","unstructured":"Foulquier, C. et al. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3 and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis & Rheumatism 56, 3541\u20133553 (2007).","journal-title":"Arthritis & Rheumatism"},{"key":"BFsrep09259_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/art.27305","volume":"62","author":"B Carames","year":"2010","unstructured":"Carames, B., Taniguchi, N., Otsuki, S., Blanco, F. J. & Lotz, M. Autophagy is a protective mechanism in normal cartilage and its aging-related loss is linked with cell death and osteoarthritis. Arthritis & Rheumatism 62, 791\u2013801 (2010).","journal-title":"Arthritis & Rheumatism"},{"key":"BFsrep09259_CR17","doi-asserted-by":"publisher","first-page":"e1003808","DOI":"10.1371\/journal.pgen.1003808","volume":"9","author":"IC Scott","year":"2013","unstructured":"Scott, I. C. et al. Predicting the risk of rheumatoid arthritis and its age of onset through modelling genetic risk variants with smoking. PLoS Genet 9, e1003808 (2013).","journal-title":"PLoS Genet"},{"key":"BFsrep09259_CR18","doi-asserted-by":"publisher","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","volume":"7","author":"J Sokolove","year":"2012","unstructured":"Sokolove, J. et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE 7, e35296 (2012).","journal-title":"PLoS ONE"},{"key":"BFsrep09259_CR19","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre, U. et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Invest. 122, 1791\u20131802 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFsrep09259_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00726-005-0235-4","volume":"29","author":"E Curis","year":"2005","unstructured":"Curis, E. et al. Almost all about citrulline in mammals. Amino Acids 29, 177\u2013205 (2005).","journal-title":"Amino Acids"},{"key":"BFsrep09259_CR21","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.bbagen.2013.03.025","volume":"1840","author":"PJ Thornalley","year":"2014","unstructured":"Thornalley, P. J. & Rabbani, N. Detection of oxidized and glycated proteins in clinical samples using mass spectrometry - A user's perspective. Biochim. Biophys. Acta 1840, 818\u2013829 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFsrep09259_CR22","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/pmic.201100478","volume":"12","author":"M De Ceuleneer","year":"2012","unstructured":"De Ceuleneer, M., Van Steendam, K., Dhaenens, M. & Deforce, D. In vivo relevance of citrullinated proteins and the challenges in their detection. Proteomics 12, 752\u2013760 (2012).","journal-title":"Proteomics"},{"key":"BFsrep09259_CR23","doi-asserted-by":"crossref","unstructured":"Seger, C. & Vogeser, M. [Pitfalls of LC-MS\/MS in the clinical laboratory]. LC-MS in Drug Bioanalysis [Xu, Q. A. & Madden, T. L. (eds.)] [109\u2013126] (Springer: New York, 2012).","DOI":"10.1007\/978-1-4614-3828-1_5"},{"key":"BFsrep09259_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0009-8981(78)90116-X","volume":"83","author":"M Roth","year":"1978","unstructured":"Roth, M. Fluorimetric determination of free hydroxyproline and proline in blood-plasma. Clin. Chim. Acta 83, 273\u2013277 (1978).","journal-title":"Clin. Chim. Acta"},{"key":"BFsrep09259_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0378-4347(01)00162-1","volume":"757","author":"H Inoue","year":"2001","unstructured":"Inoue, H., Iguch, H., Kouno, A. & Tsuruta, Y. Fluorometric determination of N-terminal prolyl dipeptides, proline and hydroxyproline in human serum by pre-column high-performance liquid chromatography using 4-(5,6-dimethoxy-2-phthalimidinyl)-2-methoxyphenylsulfonyl chloride. J. Chromatogr. B 757, 369\u2013373 (2001).","journal-title":"J. Chromatogr. B"},{"key":"BFsrep09259_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/ard.39.3.207","volume":"39","author":"D Manicourt","year":"1980","unstructured":"Manicourt, D., Brauman, H. & Orloff, S. Synovial-fluid beta-2 microglobulin and hydroxyproline fractions in rheumatoid-arthritis and non-autoimmune arthropathies. Ann. Rheumatic Dis. 39, 207\u2013216 (1980).","journal-title":"Ann. Rheumatic Dis."},{"key":"BFsrep09259_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/1759720X10378373","volume":"2","author":"CYJ Wenham","year":"2010","unstructured":"Wenham, C. Y. J. & Conaghan, P. G. The role of synovitis in osteoarthritis. Therapeutic Advances in Musculoskeletal Disease 2, 349\u2013359 (2010).","journal-title":"Therapeutic Advances in Musculoskeletal Disease"},{"key":"BFsrep09259_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0009-8981(80)90372-1","volume":"106","author":"AB Gasser","year":"1980","unstructured":"Gasser, A. B., Wootton, R., Beyeler, S., Celada, A. & Depierre, D. Biological variation in free serum hydroxyproline concentration. Clin. Chim. Acta 106, 39\u201343 (1980).","journal-title":"Clin. Chim. Acta"},{"key":"BFsrep09259_CR29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1042\/BST20140019","volume":"42","author":"N Rabbani","year":"2014","unstructured":"Rabbani, N., Shaheen, F., Anwar, A., Masania, J. & Thornalley, P. J. Assay of methylglyoxal-derived protein and nucleotide AGEs. Biochem. Soc. Trans. 42, 511\u2013517 (2014).","journal-title":"Biochem. Soc. Trans."},{"key":"BFsrep09259_CR30","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1021\/jo00441a027","volume":"42","author":"SG Ramaswamy","year":"1977","unstructured":"Ramaswamy, S. G. & Adams, E. One vessel synthesis of 4-hydroxyproline from glyoxal and oxaloacetic acid. J. Org. Chem. 42, 3440\u20133442 (1977).","journal-title":"J. Org. Chem."},{"key":"BFsrep09259_CR31","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1042\/BST20140009","volume":"42","author":"PJ Thornalley","year":"2014","unstructured":"Thornalley, P. J. & Rabbani, N. Assay of methylglyoxal and glyoxal and control of peroxidase interference. Biochem. Soc. Trans. 42, 504\u2013510 (2014).","journal-title":"Biochem. Soc. Trans."},{"key":"BFsrep09259_CR32","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1373\/clinchem.2007.087569","volume":"53","author":"N Bizzaro","year":"2007","unstructured":"Bizzaro, N., Tonutti, E., Tozzoli, R. & Villalta, D. Analytical and Diagnostic Characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins. Clin. Chem. 53, 1527\u20131533 (2007).","journal-title":"Clin. Chem."},{"key":"BFsrep09259_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S plus to analyze and compare ROC curves. BMC Bioinformatics 12, 77\u201385 (2011).","journal-title":"BMC Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep09259","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep09259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep09259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:40:20Z","timestamp":1672965620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep09259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,19]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,8,14]]}},"alternative-id":["BFsrep09259"],"URL":"https:\/\/doi.org\/10.1038\/srep09259","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,19]]},"assertion":[{"value":"16 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No authors have any competing interests apart from U.A., R.S., P.J.T. and N.R., they published a patent on this work (international publication number: WO2014016584).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9259"}}